The National Acquisition Center, a civilian agency within the U.S. Department of Veterans Affairs (VA), awarded a single-award Indefinite Delivery Contract (IDC) to Golden State Medical Supply, Inc. to provide Imatinib Mesylate tablets. The $13,958,283 contract has a base period of one year and four one-year option periods, running from February 27, 2022 to February 26, 2026.
The IDC allows the VA, Department of Defense, Bureau of Prisons, and Indian Health Service to place delivery orders against pre-established pricing for the pharmaceutical product. Golden State Medical Supply, a for-profit manufacturer and distributor of medical supplies, will serve as the sole source for Imatinib Mesylate tablets under this contract. The pre-solicitation indicated the annual estimated requirements are 7,182 bottles of 100mg tablets and 24,905 bottles of 400mg tablets. This contract award supports the critical pharmaceutical supply chain for these government healthcare facilities.
Generated 1/22/25, 9:05 AM